US Stock MarketDetailed Quotes
BNTX BioNTech
- 87.450
- +0.740+0.85%
Trading Apr 26 15:32 ET
21.07BMarket Cap21.28P/E (TTM)
88.320High86.890Low233.23KVolume87.400Open86.710Pre Close20.43MTurnover0.26%Turnover Ratio21.28P/E (Static)240.99MShares125.83052wk High0.97P/B7.89BFloat Cap85.21352wk Low--Dividend TTM90.19MShs Float457.931Historical High--Div YieldTTM1.65%Amplitude12.361Historical Low87.595Avg Price1Lot Size
BioNTech Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -77.94%3.82B | -65.43%1.48B | -74.13%895.3M | -94.75%167.7M | -79.97%1.28B | -8.78%17.31B | -22.67%4.28B | -43.14%3.46B | -39.79%3.2B | 211.20%6.37B |
| Operating revenue | -77.94%3.82B | -65.43%1.48B | -74.13%895.3M | -94.75%167.7M | -79.97%1.28B | -8.78%17.31B | -22.67%4.28B | -43.14%3.46B | -39.79%3.2B | 211.20%6.37B |
| Cost of revenue | -79.97%599.8M | -2.40%179.1M | -78.51%161.8M | -78.69%162.9M | -92.58%96M | 2.87%3B | -68.54%183.5M | -37.86%752.8M | -13.49%764.6M | 455.17%1.29B |
| Gross profit | -77.51%3.22B | -68.25%1.3B | -72.92%733.5M | -99.80%4.8M | -76.75%1.18B | -10.89%14.32B | -17.27%4.09B | -44.45%2.71B | -45.04%2.43B | 179.87%5.08B |
| Operating expense | 15.07%2.32B | 10.99%701.9M | 33.72%651.6M | -0.02%509.5M | 17.31%452M | 76.77%2.01B | 72.88%632.4M | 53.34%487.3M | 95.47%509.6M | 98.81%385.3M |
| Selling and administrative expenses | 3.05%557.7M | 3.03%149.4M | 1.07%150.8M | -8.10%132.8M | 25.21%131.6M | 65.40%541.2M | 3.72%145M | 89.58%149.2M | 136.50%144.5M | 120.80%105.1M |
| -Selling and marketing expense | 5.38%62.7M | 23.29%18M | 12.50%14.4M | 1.69%18.1M | -14.69%12.2M | 18.06%59.5M | -18.44%14.6M | 21.90%12.8M | 33.83%17.8M | 64.37%14.3M |
| -General and administrative expense | 2.76%495M | 0.77%131.4M | 0.00%136.4M | -9.47%114.7M | 31.50%119.4M | 74.02%481.7M | 6.97%130.4M | 100.00%136.4M | 165.06%126.7M | 133.42%90.8M |
| Research and development costs | 16.01%1.78B | 13.34%577.8M | 45.67%497.9M | -6.56%373.4M | 16.86%334M | 61.93%1.54B | 87.77%509.8M | 31.26%341.8M | 98.71%399.6M | 32.19%285.8M |
| Depreciation amortization depletion | ---- | ---- | 76.09%8.1M | 142.42%8M | ---- | ---- | ---- | --4.6M | --3.3M | ---- |
| -Depreciation and amortization | ---- | ---- | 76.09%8.1M | 142.42%8M | ---- | ---- | ---- | --4.6M | --3.3M | ---- |
| Other operating expenses | 61.14%-25.8M | 80.67%-2.3M | 37.35%-5.2M | 87.57%-4.7M | -142.86%-13.6M | 51.99%-66.4M | 73.85%-11.9M | 61.03%-8.3M | -2,420.00%-37.8M | 92.00%-5.6M |
| Operating profit | -92.65%904.2M | -82.73%598M | -96.31%81.9M | -126.26%-504.7M | -84.47%729M | -17.57%12.3B | -24.46%3.46B | -51.27%2.22B | -53.84%1.92B | 189.56%4.7B |
| Net non-operating interest income expense | 1,081.42%349.7M | 218.80%117M | 2,561.76%90.5M | 37.74%151.1M | 1,050.00%58.9M | 214.73%29.6M | 310.92%36.7M | 666.67%3.4M | 2,338.78%109.7M | -113.79%-6.2M |
| Non-operating interest income | 637.32%357.6M | 210.31%120.4M | 1,101.30%92.5M | 31.95%152.4M | 11,920.00%60.1M | 3,133.33%48.5M | 12,833.33%38.8M | 1,183.33%7.7M | 38,400.00%115.5M | 66.67%500K |
| Non-operating interest expense | ---- | ---- | -53.49%2M | -77.59%1.3M | ---- | ---- | ---- | 437.50%4.3M | 1,060.00%5.8M | ---- |
| Total other finance cost | -58.20%7.9M | ---- | ---- | ---- | -82.09%1.2M | -30.77%18.9M | ---- | ---- | ---- | 168.00%6.7M |
| Other net income (expense) | -110.92%-67.8M | 84.13%-51.8M | -74.95%55M | -120.40%-58.6M | -124.37%-80.2M | 327.77%620.7M | -320.91%-326.5M | 99.82%219.6M | 310.79%287.3M | 1,288.61%329.1M |
| Gain on sale of security | -106.16%-38.4M | 93.08%-22.4M | -74.95%55M | -120.40%-58.6M | -124.37%-80.2M | 304.74%623.7M | -306.31%-323.5M | 99.82%219.6M | 310.79%287.3M | 1,288.61%329.1M |
| Special income (charges) | -880.00%-29.4M | ---- | ---- | ---- | ---- | 66.67%-3M | ---- | ---- | ---- | ---- |
| -Less:Other special charges | 880.00%29.4M | ---- | ---- | ---- | ---- | -66.67%3M | ---- | ---- | ---- | ---- |
| Income before tax | -90.84%1.19B | -79.10%663.2M | -90.70%227.4M | -117.77%-412.2M | -85.90%707.7M | -13.91%12.95B | -32.70%3.17B | -47.63%2.44B | -42.35%2.32B | 205.55%5.02B |
| Income tax | -92.73%255.8M | -77.03%205.3M | -89.87%66.8M | -134.27%-221.8M | -84.42%205.5M | -25.96%3.52B | -42.24%893.9M | -54.74%659.2M | -47.61%647.3M | 156.57%1.32B |
| Net income | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B | -44.41%1.78B | -40.01%1.67B | 227.88%3.7B |
| Net income continuous Operations | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B | -44.41%1.78B | -40.01%1.67B | 227.88%3.7B |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B | -44.41%1.78B | -40.01%1.67B | 227.88%3.7B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B | -44.41%1.78B | -40.01%1.67B | 227.88%3.7B |
| Basic earnings per share | -90.02%3.87 | -79.64%1.91 | -90.98%0.67 | -111.52%-0.79 | -86.32%2.07 | -8.06%38.78 | -27.62%9.38 | -43.46%7.43 | -39.93%6.86 | 226.08%15.13 |
| Diluted earnings per share | -89.86%3.83 | -79.59%1.89 | -90.40%0.67 | -112.25%-0.79 | -85.60%2.05 | -4.69%37.77 | -23.91%9.26 | -43.48%6.98 | -40.11%6.45 | 224.37%14.24 |
| Dividend per share | ||||||||||
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg